SimpleScreen CRC
Freenome, LLC · Decision date Aug 26, 2026
What did the FDA decide?
FDA records P250029/S001 as a supplement to PMA P250029, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 26, 2026.
FDA approval order statement
changes in a supplier manufacturing processes for critical reagents
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Medical Genetics
- Decision date
- Aug 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P250029/S001
- Regulatory pathway
- PMA supplement
- Applicant
- Freenome, LLC
- Product code
- PHP
- Decision code
- OK30
- Decision date
- Aug 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, colorectal neoplasia, DNA methylation and hemoglobin detection.
- Applicant
- Freenome, LLC
- Product code
- PHP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250029. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250029 · Original PMA
SimpleScreen CRC
P250029/S001 received
Application receipt date recorded by FDA.
P250029/S001 · FDA decision
30-Day Notice
P250029/S003 · Related supplement
SimpleScreen CRC
Timeline entries are records held by MedtechLedger for P250029. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250029
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
SimpleScreen CRCP250029 | Freenome, LLC | PMA approval | Jul 24, 2026 | FDA |
SimpleScreen CRCP250029/S003 | Freenome, LLC | PMA supplement | Oct 27, 2026 | FDA |
Explore the linked device profile
Other records with product code PHP
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ShieldP230009/S021 | Guardant Health, Inc. | PMA supplement | Oct 5, 2026 | FDA |
ShieldP230009/S020 | Guardant Health, Inc. | PMA supplement | Sep 16, 2026 | FDA |
Cologuard PlusP230043/S010 | Exact Sciences Corporation | PMA supplement | Aug 3, 2026 | FDA |
ShieldP230009/S010 | Guardant Health, Inc. | PMA supplement | Jul 22, 2026 | FDA |
ShieldP230009/S018 | Guardant Health, Inc. | PMA supplement | Jul 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Freenome, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Bldg. 1, 3300 Marina Blvd., Brisbane, CA, 94005
Sources and methodology
- Original FDA record: P250029/S001
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



